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Abstract  
Introduction: Patients with type 2 diabetes mellitus (DM) are at increased risk of 
dying from cardiovascular diseases. Elevated cardiovascular risk in this population persists 
even after other conventional cardiovascular risk factors are eliminated or reduced, 
suggesting that there are other, incompletely understood, mechanisms which are increasing 
cardiovascular risk in such patients. Ventricular instability, such as that observed in QT 
abnormalities, may be an important additional mechanism. QT prolongation has been shown 
to predict cardiac death in type 2 DM. 
The aims of our study were to evaluate the prevalence of QTc prolongation in patients with 
type 2 DM and to assess the relationship between insulin resistance, evaluated by HOMA-IR 
and QTc. We also investigated the relationship between QTc and the duration of DM, 
HbA1c, plasma lipids, systolic blood pressure (SBP), diastolic blood pressure (DBP) and 
body mass index (BMI). 
Materials and method: We enrolled 104 patients with type 2 DM. For each subject, 100 
consecutive heart beats were recorded on the resting ECG tracing. QTc was calculated 
according to Bazett’s formula.  
Results and discussion: In patients with type 2 DM, the prevalence of a prolonged QTc 
interval was 34.6%. We found a significant increase, with 64 ms (p= 0.004) in QTc interval 
for the insulin resistant cohort (mean QTc= 419 ms; n= 92) compared to the sample with 
normal HOMA IR (mean QTc= 355; n=12).  
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Conclusion: Insulin resistance, estimated by HOMA-IR, was strongly correlated with 
prolonged QTc. Prolonged QTc identifies type 2 DM patients with an elevated risk of 
cardiovascular events. 
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Introduction 
Epidemiological studies have demonstrated that diabetics display a cardiovascular risk 
which is twice that of the sex- and age-matched non-diabetic population (Vinik, 2001; 
Langer, 1991). Patients with type 2 diabetes mellitus (DM) are at increased risk of dying 
from cardiovascular diseases. Excess cardiovascular risk in this population persists even after 
normalization for other conventional cardiovascular risk factors (hypertension, dyslipidemia, 
physical inactivity, smoking), suggesting that there are other incompletely understood 
mechanisms which increase cardiovascular risk in diabetic patients. Ventricular instability, as 
manifested in QT abnormalities, may be an important additional mechanism (Kumar, 2004). 
The QT interval on an electrocardiogram represents the time needed for ventricular 
repolarization. Increased length of this interval, known as corrected QT (QTc) prolongation, 
can be a precursor of torsade de pointes, a potentially life-threatening ventricular dysrhythmia 
(Pickham, 2013) and ventricular fibrillation (Jackman, 1988). Prolongation of QTc increases 
morbidity and mortality and QTc has been found to be longer in patients with DM than in 
healthy controls. 
 QT prolongation has been shown to predict cardiac death in type 2 DM. Although 
there is general agreement that the QT interval is affected by cardiac ischemia, the effect of 
hyperglycemia on QT measures is controversial. Several studies suggest that assessing the 
QT interval could be a cost-effective way of stratifying such patients according to 
cardiovascular risk so that aggressive treatment could be directed appropriately to improve 
outcome (Kumar, 2004). 
 The aims of our study were to evaluate the prevalence of QTc prolongation in patients 
with type 2 DM and to assess the relationship between QTc and insulin resistance, evaluated 
by HOMA-IR. We also evaluated the relationship between QTc and the duration of DM, 
HbA1c, plasma lipids, systolic blood pressure (SBP), diastolic blood pressure (DBP), and 
body mass index (BMI). 
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Main Text 
Materials And Method 
 Study population: We conducted a hospital-based study lasting one year – January to 
December 2012 – at the Diabetes and Nutrition Department of the Timisoara Emergency 
Clinical Country Hospital. 
 The participants were selected from patients hospitalized in the Diabetes and 
Nutrition Department of the Timisoara Emergency Clinical Country Hospital. The study 
enrolled 104 patients with type 2 DM, whose ages ranged from 26 to 76 years. The diagnosis 
and classification of their diabetes were based on guidelines of the EASD: symptoms of 
diabetes: polydipsia, polyuria, unexplained weight loss; plus a random plasma glucose >200 
mg/dL (11.1 mmol/L) or fasting plasma glucose > 126 mg/dL (7.0 mmol/L) after an 
overnight fast (at least 8 hours) or two-hour plasma glucose> 200mg/dL (11.1 mmol/L) 
during a standard 75g oral glucose tolerance test; any of these criteria establishes the 
diagnosis but needs to be confirmed some days later. We excluded those with known 
arrhythmia, unstable angina, myocardial infarction, or cerebrovascular disease, and those who 
were taking any autonomic drug such as a β-blocker, β- agonist, or calcium channel blocker. 
The study protocol was approved by the ethics committee of the Timisoara Emergency 
Clinical Country Hospital, and the participants signed to show their informed consent at the 
time of recruitment. 
Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. 
Blood pressure was measured twice (5 minutes apart) on both right and left arms after the 
participants had been sitting and calm for at least 10 minutes. The highest blood pressure of 
two sides was considered as the participant`s blood pressure.  
Patients’ baseline characteristics are presented in Table 1. 
Table 1. Baseline characteristics of the studied group 
 Entire group Men Women p (men vs. women) 
Number 104 56 (53.5%) 48 (46.2%) n/a 
Median age 52.5 ± 11.1 51.3 ± 10.1 53.8 ± 12.1 0.251 
Median diabetes 
duration 6.2 ± 6 5.7 ± 6.2 6.75 ± 5.8 0.378 
HbA1c (%) 10.02 ± 2.46 10.05 ± 2.26 9.97 ± 2.7 0.083 
HOMA-IR  4.36 ± 2.47 4.53 ± 2.3 4.17 ± 2.67 0.459 
BMI (kg/m2) 30.6 ± 6.4 29.91 ± 4.84 31.53 ± 7.84 0.201 
SBP (mmHg) 133.8 ± 19.4 135.9 ± 20.52 131.2 ± 18 0.21 
DBP (mmHg) 82.7 ± 12.5 85.0 ± 12.49 80.1 ± 12.13 0.045 
Triglycerides 
(mg/dL) 233.3 ± 147.5 259.1 ± 145.1 203.29 ± 146.16 0.054 
Total cholesterol 
(mg/dL) 213.6 ± 57.6 215.16 ± 63.61 211.83 ± 50.21 0.77 
HDLc (mg/dL) 37.9 ± 11.4 35.18 ± 8.13 41.08 ± 13.75 0.008 
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Values are expressed as means ± standard deviations. P was assessed using an 
unpaired t-student test.  
The homeostasis model assessment (HOMA) index was calculated as the product of 
the peptide C (pmol/l) level and the fasting plasma glucose level (mmol/L) divided by 2800, 
plus 1.5. 
QTc: The evaluation of QTc was performed in a quiet and temperature-controlled 
room, participants having been advised to abstain from caffeinated food and beverages on the 
day of their assessments. Repeated assessments were performed at precisely the same time of 
day after 48 hours. After 15 minutes of supine rest with a regular and calm breathing pattern, 
100 consecutive heart beats were recorded on the ECG tracing. QT and RR intervals were 
measured with a rule for 5 consecutive beats on the V5 lead on the resting ECG tracing. QTc 
was calculated according to Bazett’s formula. Any QTc > 0.44s was considered abnormally 
prolonged. 
Statistical methods: Statistical analysis was performed using IBM SPSS v. 15 and 
Graph Pad Prism v.5. In order to assess the significance of differences, an unpaired t-student 
test for parametrical variables and the Mann-Whitney test for non-parametrical data were 
used (means), together with Fisher’s exact test for proportions. To assess the interdependence 
between variables, univariate and multivariate regression models were developed. To obtain 
the analysis B coefficient, β exponent and Pearson’s correlation coefficient were used, their 
significance being calculated using a t-distribution test. 
Results 
Normal HOMA-IR was found in 12 patients, while 92 had HOMA-IR values over 2.4. In 
the entire group, the prevalence of a prolonged QTc interval was 34.6 % (24.24% to 47.9%; 
95% CI). The prevalence was not significantly different in men (30.4%) and in women 
(39.6%), p=0. 41 (Fisher’s exact test).  
 The insulin resistant cohort (mean QTc=419. 8 ms) had an increased mean corrected 
QT interval with 64.3 ms compared to the normal HOMA-IR cohort (mean QTc=355. 5 ms), 
the differences being statistically significant (p=0. 004; unpaired t-student test). The 
percentage of patients presenting prolonged QTc were 39.1% in the insulin resistant group 
while none of the patients with normal HOMA-IR had a QTc interval over 440ms.  
The corrected QT interval is strongly positive and statistically significant correlated with 
HOMA-IR values (Pearson r=0.62; p< 0.001 t-distribution test), meaning that the QTc 
interval increases once with HOMA-IR (Figure 1). 
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Figure 1. The correlation between HOMA-IR and QTc 
  In order to assess the influence of individual factors (HOMA-IR, HbA1c, age, 
diabetes duration and BMI), we fitted these on a multivariate regression model, having as 
outcome the length of the QTc interval. The results reveal the significant involvement of 
HOMA-IR, age and HbA1c on the QTc interval, whereas diabetes duration and BMI were not 
significant when correlated with the length of the QTc interval (Table 2). 
Table 2. Multivariate regression results. 
Predictor B (95% CI) Exp (β) p 
HOMA-IR 1.76 (1.3 to 2.2) 0.58 < 0.001 
Age 0.125 (0.02 to 0.25) 0.158 0.048 
Diabetes duration 0.028 (-0.18 to 0.23) 0.023 0.786 
HbA1c 0.37 (0.23 to 0.61) 0.146 0.041 
BMI 0.119 (-0.068 to 0.307) 0.014 0.208 
   
Discussion 
Cardiac autonomic neuropathy is a well-recognized complication of diabetes and is 
believed to be responsible for an increased risk of sudden death. Prolonged QTc is an 
independent marker for CHD risk in type 2 diabetes (Veglio, 2002) and has been 
demonstrated to be a highly significant predictor of cardiac death (Sawicki, 1996), even in 
newly diagnosed type 2 diabetes. The prevalence of a prolonged QTc interval is higher in 
people with type 2 diabetes than in non-diabetic subjects (Veglio, 2002; Veglio, 1999) in 
particular in the presence of autonomic neuropathy (Sivieri, 1993). The prevalence of QT 
prolongation has been reported to be as high as 26% in type 2 diabetes (Veglio, 2002). 
However, even patients with a recent diagnosis of diabetes and without overt cardiac 
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complications have been observed to have an increased QTc compared to non-diabetic 
subjects (Cardoso, 2001). The QT interval is affected by CHD and autonomic neuropathy and 
it is possible that these new diabetic patients with prolonged QT interval may have had 
undiagnosed neuropathy or CHD. 
It is already known that hyperglycemia induces ventricular instability manifested by 
increases of the QTc interval (Pickham, 2013). Many studies discuss the involvement not 
only of the hypoglycemic state in the QTc prolongation but also the involvement of the 
hyperinsulinic state, which is mainly caused by insulin resistance (Dekker, 1996). 
Hyperinsulinemia and insulin resistance have been implicated as key factors in the etiology 
of coronary heart disease (DeFronzo, 1991). They provide a basis for the clustering of several 
risk factors. Genetic predisposition, lack of physical activity, and positive energy balance, 
followed by increased body weight, result in high insulin levels. Hyperinsulinemia notably 
increases the triglyceride level and lowers HDL cholesterol. QTC prolongation and its 
sequelae may be an additional feature of this cluster (Dekker, 1996). 
 Animal studies have shown that glucose-insulin infusion reduces and improves the 
associated conduction delay (Bekheit, 1993). Altered ion exchange activities may be induced 
by reduced myocardial glucose uptake resulting from impaired insulin binding (Almira, 
1986). Hyperinsulinemia and disturbed glucose uptake may contribute to a longer QTc 
(Dekker, 1996). 
HOMA-IR represents the actual accepted indicator for assessing the insulin-resistance, 
the key component of the Metabolic Syndrome. Besides its already known effects on the 
metabolic state, increased insulin resistance may be involved in a series of poorly 
investigated outcomes, one of them being ventricular instability, manifested by increases in 
repolarization which can be assessed by calculating the corrected QTc interval.  
Our results demonstrate that the presence of insulin resistance causes an increase in the 
mean QTc interval, which is statistically significant. Not only is this mean increased, but 
being in the insulin-resistant cohort causes a major increase in the probability of having a 
corrected QT interval over the cutoff value of 440 ms which the international guidelines 
consider to be the maximum safe value. These results are sustained by the tight positive 
correlation between the HOMA-IR levels and QTc intervals encountered, QTc being a 
recognized predictor of serious cardiac rhythm events, potentially life threatening, such as 
torsade de pointes (Pickham, 2013) and ventricular fibrillation (Jackman, 1988), which 
indirectly involve insulin resistance in this chain of occurrences.  
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The multivariate regression model indicates that insulin resistance is involved in 
prolonging the QTc interval both in association with other predictors (in our case age and 
HbA1c) and also independently, suggesting that improving the insulin resistance could have 
an important role in normalizing the QTc interval and so reducing the risk of coronary heart 
disease and sudden death. 
Conclusions 
Insulin resistance, estimated by HOMA-IR, was closely correlated with prolonged 
QTc. No association between QTc and gender has been observed in type 2 DM. Prolonged 
QTc identifies type 2 DM patients as having an elevated risk of cardiovascular events. No 
association between QT abnormalities and gender has been observed in type 2 diabetes. 
Diabetic patients with more pronounced QT abnormalities tend to have higher age and blood 
pressure and they tend to have cardiovascular complications. 
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